Item | Information |
---|---|
CAS RN | 151-67-7 |
Chemical Name | 2-Bromo-2-chloro-1,1,1-trifluoroethane (Halothane) |
Substance ID | H26-B-084, - |
Classification year (FY) | FY2014 |
Ministry who conducted the classification | Ministry of Health, Labour and Welfare (MHLW)/Ministry of the Environment (MOE) |
New/Revised | Revised |
Classification result in other fiscal year | FY2006 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | GHS Classification Guidance for the Japanese Government (FY2013 revised edition) |
UN GHS document (External link) | UN GHS document |
Definitions/Abbreviations (Excel file) | Definitions/Abbreviations |
Model Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Model SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | eChemPortal |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
1 | Explosives | Not applicable |
- |
- | - | There are no chemical groups associated with explosive properties present in the molecule. |
2 | Flammable gases (including chemically unstable gases) | Not applicable |
- |
- | - | Liquid (GHS definition) |
3 | Aerosols | Not applicable |
- |
- | - | Not aerosol products. |
4 | Oxidizing gases | Not applicable |
- |
- | - | Liquid (GHS definition) |
5 | Gases under pressure | Not applicable |
- |
- | - | Liquid (GHS definition) |
6 | Flammable liquids | Not classified |
- |
- | - | It is not combustible (ICSC (2003)). |
7 | Flammable solids | Not applicable |
- |
- | - | Liquid (GHS definition) |
8 | Self-reactive substances and mixtures | Not applicable |
- |
- | - | There are no chemical groups present in the molecule associated with explosive or self-reactive properties. |
9 | Pyrophoric liquids | Not classified |
- |
- | - | It is not combustible (ICSC (2003)). |
10 | Pyrophoric solids | Not applicable |
- |
- | - | Liquid (GHS definition) |
11 | Self-heating substances and mixtures | Not classified |
- |
- | - | It is not combustible (ICSC (2003)). |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Not applicable |
- |
- | - | The chemical structure of the substance does not contain metals or metalloids (B, Si, P, Ge, As, Se, Sn, Sb, Te, Bi, Po, At). |
13 | Oxidizing liquids | Not applicable |
- |
- | - | The substance is an organic compound containing fluorine and chlorine (but not oxygen) which are chemically bonded only to carbon or hydrogen. |
14 | Oxidizing solids | Not applicable |
- |
- | - | Liquid (GHS definition) |
15 | Organic peroxides | Not applicable |
- |
- | - | Organic compounds containing no bivalent -O-O- structure in the molecule |
16 | Corrosive to metals | Classification not possible |
- |
- | - | Test methods applicable to low-temperature-boiling liquids are not available. |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. Besides, although there was a report of an LD50 value of 5,680 mg/kg for rats (GESTIS (Access on September 2014), RTECS (Access on September 2014)), each was an information source in List 3 and it was not possible to confirm by an original source, therefore, it was not adopted for classification. A new information source (GESTIS (Access on September 2014)) was added, and the category was revised. |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
1 | Acute toxicity (Inhalation: Gases) | Not applicable |
- |
- | - | Liquid (GHS definition) |
1 | Acute toxicity (Inhalation: Vapours) | Category 4 |
Warning |
H332 |
P304+P340
P261 P271 P312 |
Based on reports of an LC50 value (4 hours) of 120,000 mg/m3 (14,880 ppm) for rats (RTECS (Access on September 2014)), and of an LC50 value (10 minutes) of 22,000 ppm (converted 4-hour equivalent value: 4,510 ppm) for mice (Sax's Dangerous Properties of Industrial Materials (2012)), it was classified in Category 4. Besides, since the LC50 values were lower than 90% of the saturated vapor concentration (319,842 ppm), the reference value in units of ppm was applied as a vapour without a mist. New information sources (RTECS (Access on September 2014), Sax's Dangerous Properties of Industrial Materials (2012)) were added, and the category was revised. Besides, although RTECS was the information source listed in List 3 and it was not possible to confirm by an original source, this substance is used as a pharmaceutical substance, therefore, it was classified including the information in RTECS. |
1 | Acute toxicity (Inhalation: Dusts and mists) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
2 | Skin corrosion/irritation | Classification not possible |
- |
- | - | Classification not possible due to lack of data. Besides, although there is a description that it might irritate the skin by overexposure (HSDB (Access on August 2014)), these data were judged as insufficient for use in the classification since the details were unknown. |
3 | Serious eye damage/eye irritation | Category 2A |
Warning |
H319 |
P305+P351+P338
P337+P313 P264 P280 |
In an eye irritation test with rabbits, although severe irritation such as corneal opacity and swelling of the conjunctiva were observed, there was no description about irreversible lesions (RTECS, original reference (Federation Proceedings vol. 35 (1976))). From the above result, it was classified in Category 2A. |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
4 | Skin sensitization | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
5 | Germ cell mutagenicity | Classification not possible |
- |
- | - | Classification not possible due to lack of data. There were no in vivo data. As for in vitro, it was negative in a bacterial reverse mutation test, a chromosomal aberration test and a sister chromatid exchange test with cultured mammalian cells (ACGIH (7th, 2001), NTP DB (Access on September 2014), HSDB (Access on August 2014)). |
6 | Carcinogenicity | Classification not possible |
- |
- | - | Since it was classified in A4 by ACGIH (7th, 2001), it was classified as "Classification not possible." Besides, there was a classification as "Anaesthetise, volatile (Group 3)" in IARC (IARC Suppl 7 (1987)). |
7 | Reproductive toxicity | Category 2 |
Warning |
H361 |
P308+P313
P201 P202 P280 P405 P501 |
In a study with rats exposed by inhalation at 10 ppm during gestation, liver damage were observed in offspring (ACGIH (7th, 2001), IARC vol. 11 (1976)). This test was conducted with only one dose, and there was no description of maternal toxicities, therefore, it was classified in Category 2. Besides, there is a description that in a study with rats exposed by inhalation at 10 ppm in early development (from conception to 60 days old), impairments in learning ability occurred (IARC vol. 11 (1976)). On the other hand, there is a report that by inhalation exposure with mice before mating and during gestation, no effects on the course of pregnancy and fetal development were observed (ACGIH (7th, 2001)). In addition, there is a report that by inhalation exposure with rats during gestation, although reduction of fetal weight was observed, no differences were observed in litter size, fetal ossification and skeletal abnormalities compared with the control group (ACGIH (7th, 2001)). |
8 | Specific target organ toxicity - Single exposure | Category 1 (cardiovascular system, liver), Category 3 (narcotic effects) |
Danger Warning |
H370
H336 |
P308+P311
P260 P264 P270 P321 P405 P501 P304+P340 P403+P233 P261 P271 P312 |
This substance is used as an inhalation anesthetic for pharmaceutical uses. In humans, effects on the liver (hepatitis, hepatic dysfunction), effects on the central nervous system (amnesia, analgesia, anesthesia, respiratory depression), effects on the cardiovascular system (arrhythmia, vasodilatation, hypotension, bradycardia) were observed as acute effects. Liver impairment occasionally resulted from clinical anesthesia and usually occurred in patients who were previously anesthetized with halothane. In addition, vomiting, gastroenteritis, depression of consciousness, hypotension, shallow breathing, bradycardia and coma were reported by oral ingestion (ACGIH (7th, 2001), HSDB (Access on August 2014)). Therefore, the acute effects of this substance were considered to be narcotic effects and effects on the cardiovascular system and liver. There were no data in experimental animals. From the above, it was classified in Category 1 (cardiovascular system, liver), Category 3 (narcotic effects). |
9 | Specific target organ toxicity - Repeated exposure | Category 1 (liver) |
Danger |
H372 |
P260
P264 P270 P314 P501 |
In ACGIH (7th, 2001), there are reports on cases of humans who developed liver impairment by chronic exposure to this substance. It is described that in an epidemiological study in anesthetists in Czechoslovakia, an increase in the incidence of symptomatic cases such as headache and fatigue was observed among 163 anesthetists who were exposed in operating rooms where halothane concentrations were 2-4 ppm, and the onset of hepatitis was 3 times more frequent in the anesthetists than in the general population, and that in 13 workers engaged in manufacturing at a halothane manufacturing plant and exposed to halothane at an average of 660 ppm, symptoms similar to those in the anesthetists were observed, and serum AST and ALT activities were above normal levels in 1/3 of them (ACGIH (7th, 2001)). As for experimental animals, since there are descriptions that rats and rabbits were exposed by inhalation to this substance (estimated as the vapor) at 500 ppm (converted guidance value: 2.53 mg/L/6 hours) with for 7 weeks and developed centrilobular fatty infiltration of the liver (ACGIH (7th, 2001)), and that hepatic necrosis occurred in guinea pigs by repeated exposure to halothane, and hepatic necrosis may also be induced in rats by halothane anesthesia under hypoxic conditions (14%) after induction of hepatic microsomal drug-metabolizing enzymes (ACGIH (7th, 2001), PATTY (6th, 2012)), they were considered to be findings supporting liver damage in humans although those were not available for classification. From the above, based on findings in humans and experimental animals, it was classified in Category 1 (liver). Besides, although the substance was classified based only on toxicity information in experimental animals in the previous classification, it was classified including human findings this time. |
10 | Aspiration hazard | Classification not possible |
- |
- | - | Classification not possible due to lack of data. |
Hazard class | Classification |
Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | |
---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment (Acute) | - |
- |
- | - | - |
11 | Hazardous to the aquatic environment (Long-term) | - |
- |
- | - | - |
12 | Hazardous to the ozone layer | - |
- |
- | - | - |
|